Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Acute life-threatening reversible pulmonary vasoconstrictive reaction to bleomycin chemotherapy demonstrating the clinical application of ePLAR - echocardiographic Pulmonary to Left Atrial Ratio.

Waldie AM, Eliadis PE, Fraser JF, Little SG, Scalia IG, Scalia GM.

Int J Cardiol. 2016 Jul 15;215:438-40. doi: 10.1016/j.ijcard.2016.04.141. Epub 2016 Apr 19. No abstract available.


SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.

van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, Perez D, Robinson BA, Strickland AH, Ferguson T, Rodríguez J, Kröning H, Wolf I, Ganju V, Walpole E, Boucher E, Tichler T, Shacham-Shmueli E, Powell A, Eliadis P, Isaacs R, Price D, Moeslein F, Taieb J, Bower G, Gebski V, Van Buskirk M, Cade DN, Thurston K, Gibbs P.

J Clin Oncol. 2016 May 20;34(15):1723-31. doi: 10.1200/JCO.2015.66.1181. Epub 2016 Feb 22.


Rapid elevation of transferrin saturation and serum hepcidin concentration in hemodialysis patients after intravenous iron infusion.

Kitsati N, Liakos D, Ermeidi E, Mantzaris MD, Vasakos S, Kyratzopoulou E, Eliadis P, Andrikos E, Kokkolou E, Sferopoulos G, Mamalaki A, Siamopoulos K, Galaris D.

Haematologica. 2015 Mar;100(3):e80-3. doi: 10.3324/haematol.2014.116806. Epub 2014 Nov 25. No abstract available.


A multicenter, open-label, noncomparative screening study of enzastaurin in adult patients with non-Hodgkin lymphomas.

Forsyth CJ, Gomez-Almaguer D, Camargo JF, Eliadis PE, Crespo-Solis E, Pereira J, Gutierrez-Aguirre CH, Rivas-Vera S, Roberson S, Lin B, Smith NV, Hamid O.

Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):398-403. doi: 10.1016/j.clml.2013.03.005. Epub 2013 Jun 14.


A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.

Bradstock KF, Matthews JP, Lowenthal RM, Baxter H, Catalano J, Brighton T, Gill D, Eliadis P, Joshua D, Cannell P, Schwarer AP, Durrant S, Gillett A, Koutts J, Taylor K, Bashford J, Arthur C, Enno A, Dunlop L, Szer J, Leahy M, Juneja S, Young GA; Australasian Leukaemia and Lymphoma Group.

Blood. 2005 Jan 15;105(2):481-8. Epub 2004 Jun 22.


Angioedema in the emergency department: a presentation of lymphoma.

Wellwood J, Taylor K, Wright S, Bentley M, Eliadis P.

Emerg Med (Fremantle). 2001 Dec;13(4):465-8.


Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.

Bradstock K, Matthews J, Young G, Lowenthal R, Baxter H, Arthur C, Bashford J, Brighton T, Cannell P, Dunlop L, Durrant S, Enno A, Eliadis P, Gill D, Gillett A, Gottlieb D, Januszewicz H, Joshua D, Leahy M, Schwarer A, Taylor K; Australian Leukaemia Study Group.

Leukemia. 2001 Sep;15(9):1331-8.


Long-term interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemia.

Bentley M, Taylor K, Grigg A, Kronenberg H, Gibson J, Bunce I, Eliadis P, Olsen T, Wright S, Taylor D, Rodwell R.

Leuk Lymphoma. 1999 Dec;36(1-2):123-8.


A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG).

Lowenthal RM, Bradstock KF, Matthews JP, Bishop JF, Juneja S, Cobcroft R, Eliadis P, Enno A, Gill D, Herrmann RP, Manoharan A, Page FJ, Rooney KF, Rosenfeld D, Seldon M, Taylor KM, Wolf MM, Young GA.

Leuk Lymphoma. 1999 Aug;34(5-6):501-10.


Efficacy, safety and tolerability of anagrelide in the treatment of essential thrombocythaemia.

Mills AK, Taylor KM, Wright SJ, Bunce I, Eliadis P, Brigden MC, Seeley G, Bashford J, Olsen T, Rentoul A, Kelly C.

Aust N Z J Med. 1999 Feb;29(1):29-35.


Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor.

Morton J, Mollee P, Taylor K, Grigg A, Durrant S, Moore D, Rodwell R, Eliadis P, Hutchins C, Williams B, Seeley G, Wright S, Kelly C, Rentoul A, Iland H, Atkinson K, Januszewicz H, Bunce I, Bashford J, Stewart C, Taylor D.

Leuk Res. 1999 Feb;23(2):177-83.


High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group.

Morton J, Taylor K, Bunce I, Eliadis P, Rentoul A, Moore D, Kelly C, Wright S, Bashford J, Rodwell R, Rooney K, Mulligan S, Firkin F, Dodds A, Parkin J, Lowenthal R, Kimber R, Frost T, Grigg A, Goldstein D, Stone J, Lee N.

Br J Haematol. 1996 Oct;95(1):110-5.


Psychosocial benefits of postmastectomy lymphedema therapy.

Mirolo BR, Bunce IH, Chapman M, Olsen T, Eliadis P, Hennessy JM, Ward LC, Jones LC.

Cancer Nurs. 1995 Jun;18(3):197-205.


Cytogenetic response to alpha-interferon is predicted in early chronic phase chronic myeloid leukemia by M-bcr breakpoint location.

Elliott SL, Taylor KM, Taylor DL, Rodwell RL, Williams BF, Shuttlewood MM, Wright SJ, Eliadis PE, Bunce IH, Frost TJ, et al.

Leukemia. 1995 Jun;9(6):946-50.


Interferon for subfoveal choroidal neovascularisation.

Groeneveld E, Eliadis P.

Aust N Z J Ophthalmol. 1993 May;21(2):133-4. No abstract available.


Supplemental Content

Loading ...
Support Center